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Objectives: We performed a post hoc analysis of the Arterial Revascularization Trial to 40 
compare 10-year outcome after off-pump vs on-pump surgery. 41 
Methods: Among 3102 patients enrolled, 1252 (40% of total) and 1699 patients received off-42 
pump and on-pump surgery (and 151 were excluded because of other reasons); 2792 (95%) 43 
patients completed 10-year follow-up. Propensity matching and mixed effect Cox model were 44 
used to compare long term outcomes. Interaction term analysis was used to determine whether 45 
bilateral internal thoracic artery grafting was a significant effect modifier.  46 
Results: 1078 matched pairs were selected for comparison. A total of 27 patients (2.5%) in the 47 
off-pump group required conversion to on-pump surgery. The off-pump and on-pump group 48 
received a similar number of grafts (3.2±0.89 vs 3.1±0.8; P=0.88). At 10 years, when compared 49 
to on-pump, there was no significant difference  in death  (adjusted HR for odd-pump: 1.1; 50 
95%CI 0.84-1.4; P=0.54) or the composite of death, myocardial infarction, stroke and repeat 51 
revascularization (adjusted HR 0.92; 95%CI 0.72-1.2; P=0.47). However, off-pump surgery 52 
performed by low volume off-pump surgeons was associated with a significantly lower number 53 
of grafts, increased conversion rates and an increased cardiovascular death (HR 2.39; 95%CI 54 
1.28-4.47; P=0.006) when compared to on-pump surgery performed by “on-pump only” 55 
surgeons.  56 
Conclusions: The present findings showed that in the Arterial Revascularization Trial off-57 
pump and on-pump techniques achieved comparable long-term outcomes. However, when off-58 
pump surgery was performed by low volume surgeons, it was associated with a lower number 59 
of grafts, increased conversion and a higher risk of cardiovascular death.  60 
 61 





Ultra-mini abstract 63 
In experienced hands, off-pump surgery can achieve long term outcomes comparable to those 64 
observed after on-pump surgery and can therefore be considered a valid alternative to on-pump 65 
to reduce surgical morbidity. The choice of bilateral vs. single internal thoracic artery grafts 66 







Whether off-pump coronary artery bypass graft (CABG) surgery is as safe and effective as on-70 
pump surgery remains one of the most controversial areas of cardiac surgery.1 Some 71 
randomized controlled trials (RCT) have found increased mortality following off-pump 72 
surgery1,2 but limited surgeon off-pump experience has been advocated to explain these 73 
results.2 On the other hand, off-pump has been shown to achieve results comparable to on-74 
pump surgery when performed by experienced surgeons.3,4 However, available RCTs are 75 
limited by relatively short follow-up duration (5 years) and differences in clinical outcomes 76 
may become evident with longer follow-up duration.5  77 
Moreover, available data comparing off-pump and on-pump surgery were based on a single 78 
internal thoracic artery graft (SITA) supplemented by saphenous vein grafts (SVGs).2–4  There 79 
is growing concern that off-pump surgery is associated with a significantly higher graft failure 80 
rate when SVGs but not arterial grafts are used.6  Therefore, it has been suggested that a more 81 
extensive use of arterial grafts including bilateral internal thoracic artery (BITA) grafts should 82 
be adopted during off-pump surgery.6,7  83 
The Arterial Revascularization Trial (ART) was designed to compare 10-year survival after 84 
BITA versus SITA grafting and the final results have recently reported.8  In the ART, the choice 85 
of off-pump versus on-pump was based on the surgeon's preference in accordance with their 86 
clinical expertise. As such, the ART trial may provide useful insights into the long-term effect 87 
of off-pump surgery when performed by surgeons who use it routinely in clinical practice. 88 
Moreover, the ART trial can provide further information regarding the role of BITA vs. SITA 89 
grafting in patients undergoing off-pump surgery. We performed a post-hoc analysis to 90 
compare 10-year outcomes after off-pump vs on-pump surgery and the effect of BITA vs. SITA 91 
grafting.  92 





Materials and Methods 94 
The present study is a post hoc retrospective analysis of 10-year outcomes of the ART trial. 95 
The study was approved by an institutional review committee and the subjects gave informed 96 
consent. The data that support the findings of this study are available from the corresponding 97 
author upon reasonable request. The study adheres to the principles set forth in the Declaration 98 
of Helsinki (http://www.wma.net/en/30publications/10policies/b3/index.html). In the ART, 99 
the choice of off-pump versus on-pump surgery was based on individual surgeon discretion in 100 
accordance with their routine clinical practice. The off-pump versus on-pump strategy adopted 101 
was available for all patients enrolled.  102 
Among all patients enrolled in the ART (n = 3102, from 2004 to 2007), we excluded a total of 103 
151 patients including those who did not undergo surgery (n = 24), incomplete information 104 
regarding the use of cardiopulmonary bypass and myocardial protection strategy (n=6),  105 
patients who received on-pump beating heart surgery (n = 23) and 98 patients who received 106 
cross clamp fibrillation. The present analysis compared 1252 patients who underwent off-pump 107 
surgery versus 1699 patients who underwent on-pump with cardioplegic arrest. Off-pump 108 
surgery requiring intraoperative conversion to on-pump was included in the off-pump group in 109 
the primary analysis (Supplementary Figure 1).  110 
Trial Design 111 
The ART was approved by the institutional review board of all participating centers, and 112 
informed consent was obtained from each participant. The protocol for the ART has been 113 
published.9 Briefly, the ART is a 2-arm, randomized multicenter trial conducted in 28 hospitals 114 
in 7 countries, with patients being randomized equally to SITA or BITA grafting. Eligible 115 
patients were those with multivessel coronary artery disease undergoing coronary artery bypass 116 
grafting, including patients requiring urgent treatment. Only patients requiring emergency 117 
treatment (refractory myocardial ischemia/cardiogenic shock) and patients requiring single 118 






Questionnaires were sent to study participants by mail at 12 months and then every year after 121 
surgery. No clinic visits were planned apart from the routine clinical 6-week postoperative 122 
visit. Participants were sent stamped addressed envelopes to improve the return rates of postal 123 
questionnaires. Study coordinators contacted participants by telephone to alert them to the 124 
questionnaire's arrival and to ask them about medications, adverse events, and health services 125 
resource use. A total of 2792 (95%) patients completed 10-year follow-up. Median follow-up 126 
time was 10.0 [interquantile range 9.3-10.0] years.  127 
Study Outcomes 128 
The 2 strategies were compared in terms of hospital and 10-year outcomes. The primary 129 
endpoint was all-cause mortality. We also investigated the incidence cardiovascular death, 130 
nonfatal myocardial infarction (MI), nonfatal stroke, and repeat revascularization and a 131 
combined endpoint of death, MI, stroke and repeat revascularization. Adverse events were 132 
adjudicated blind to surgical procedure by a member of the Clinical Event Review Committee. 133 
Outcomes Definitions 134 
Death was classified into cardiovascular and non-cardiovascular, when possible, using autopsy 135 
reports and death certificates. Congestive heart failure, arrhythmia or MI, pulmonary embolus, 136 
and dissection were considered cardiovascular causes of death. MI was diagnosed when 2 of 137 
the following 3 criteria were present: (1) unequivocal electrocardiogram changes; (2) elevation 138 
of cardiac enzyme(s) above twice the upper limit of normal or diagnostic troponin increases; 139 
and (3) chest pain typical for acute MI that lasted more than 20 minutes. Cerebro-vascular 140 
accident (CVA) was defined as new neurologic deficit evidenced by clinical signs of paresis, 141 
plegia, or new cognitive dysfunction including any mental status alteration lasting more than 142 
24 hours or evidence on computed tomography or magnetic resonance imaging scan of recent 143 
brain infarct (<6 months). Repeat revascularization was defined as coronary bypass surgery or 144 





defined as a 0.3 mg/dL (≥26.5 mmol/L) creatinine increase from baseline within 48 hours of 146 
surgery. 147 
Statistical Analysis 148 
Multiple imputation (m = 3) was used to address missing data. Rubin's method was used to 149 
combine results from each of the imputed data sets (Amelia R package).10 Because of the lack 150 
of randomization with regard to receiving off-pump, a propensity score was generated for each 151 
patient from a multivariable logistic regression model based on pretreatment covariates listed 152 
in Table 1. Pairs of patients were derived using greedy 1:1 matching with a caliper of width of 153 
0.005 (nonrandom R package). As the sample size of the two groups was comparable as well 154 
as the prevalence of most pre-matching features, we used a more restrictive value than the 0.2 155 
standard deviation of the logit of PS in order to obtain comparable pairs. The quality of the 156 
match was assessed by comparing selected pretreatment variables in propensity score–matched 157 
patients using the standardized mean difference, with an absolute standardized mean difference 158 
(SMD) of greater than 0.10 taken to represent meaningful covariate imbalance.11 McNemar's 159 
test and paired t test were used to assess the statistical significance of the risk difference for 160 
hospital outcomes. In absence of competing events, the 1 minus Kaplan-Meier estimator was 161 
used to calculate cumulative incidence function with its relative 95% standard error while the 162 
Fine and Gray approach was used to account for presence of competing risk on a 163 
subdistribution hazard function.  164 
Event rates for 10-years outcomes were calculated according to Kaplan–Meier estimates and 165 
were compared using a stratified log-rank test. The treatment effect on the 10-year outcomes 166 
was investigated by means of mixed effect Cox regression models stratified by matched pairs 167 
(coxme R package). This approach accounts for the within-pair homogeneity by allowing the 168 
baseline hazard function to vary across matched sets.11 Individual surgeon ID was used as a 169 
random effect to account for any clustering effect due to different individual surgeons. Risk 170 





cardiovascular death. The Schoenfeld residuals test was used to test the independence between 172 
residuals and time, and thus to test the proportional hazards assumption in Cox models. 173 
Treatment effect was reported as hazard ratio (HR) and 95% confidence interval (95%CI).  174 
As sensitivity analysis, the treatment effect was re-estimated by further adjustment for 175 
medications at discharge. Subgroup and interaction term analyses were performed to 176 
investigate whether BITA vs SITA grafting was a potential effect modifier in the comparison 177 
between off-pump vs. on-pump surgery. We also investigate the interaction between off-pump 178 
vs on-pump surgery and the use of the radial artery (RA) and the use of multiple arterial grafting 179 
(MAG) defined as the use of 2 or more arterial grafts.   180 
To account for the potential influence of individual surgeons' off-pump experience, we 181 
compared off-pump vs on-pump surgery stratified by surgeon expertise in off-pump surgery. 182 
The number of off-pump procedure within the trial was used as proxy for individual surgeon 183 
expertise in off-pump surgery. The cut-off to define high off-pump volume surgeons 184 
corresponded to the 75th percentiles of total number of off-pump cases performed by each off-185 
pump surgeon (10 off-pump surgeries). Five groups were compared: 1) off-pump surgery 186 
performed by “high off-pump volume” surgeon; 2) off-pump surgery performed by “low off-187 
pump volume” surgeon; 3) on-pump surgery performed by “high off-pump volume” surgeon; 188 
4) on-pump surgery performed by “low off-pump volume” surgeon; 5) on-pump surgery 189 
performed by “on-pump only” surgeon. The treatment effect on outcomes of interest was 190 
investigated using mixed Cox models using individual surgeon as random effect (random 191 
intercept) and all baseline characteristics as fixed effect. On-pump surgery performed by “on-192 
pump only” surgeons was considered as refence group. To investigate the effect of surgeon 193 
off-pump volume, the original sample was used. A p-value less than 0.05 was considered 194 
statistically significant. All statistical analysis was performed using R Statistical Software 195 







The unmatched sample consisted of 1699 and 1252 patients undergoing off-pump vs on-pump 199 
surgery respectively (Supplementary Table 1, Supplementary Table 2). Overall, the off-200 
pump group presented a trend toward a higher risk profile including increased creatinine level 201 
and higher prevalence of unstable angina. The prevalence of 3 vessel disease was also higher 202 
among off-pump patients  and the quality of native vessels tended to be worse. BITA grafts 203 
were more likely to be used in the off-pump group while a radial artery was more likely to be 204 
used in the on-pump group. Propensity score matching identified 1078 pairs (total matched 205 
sample = 2156) for final comparison, balanced for all baseline characteristics (SMD<0.10, 206 
Table 1) and propensity score distribution was comparable between the two matched groups 207 
(Figure 1).   208 
Hospital outcomes 209 
In-hospital outcomes in the matched sample are reported in Table 2. A total of 27 patients 210 
(2.5%) in the off-pump group required conversion to on-pump surgery. The off-pump and on-211 
pump group received a comparable number of total grafts (3.2±0.89 vs 3.1±0.8; P=0.88). Off-212 
pump surgery resulted in a lower rate of transfusion and a lower incidence of post-operative 213 
atrial fibrillation and peri-operative MI with a marginally non-significant reduction of CK-MB 214 
release postoperatively. In-hospital mortality, stroke and repeat revascularization was 215 
comparable between the two groups. Patients undergoing off-pump surgery were more likely 216 
to be discharged on dual antiplatelet therapy, but they were less likely to receive statins 217 
(Supplementary Table 3). 218 
10-year outcomes 219 
10-year outcomes and treatment effect are summarized in Table 3. The incidence of all-cause 220 
mortality and the composite of death, MI, stroke and revascularization was 232 (21.5%) vs 215 221 





2). When compared to on pump, off-pump surgery was not associated with increased risk of 223 
all-cause death (HR 1.1; 95%CI 0.84-1.4; P=0.47) nor the composite of death, MI, stroke and 224 
revascularization (HR 0.92; 95%CI 0.72-1.2; P=0.47). No significant differences were 225 
recorded for composite outcome individual components (Figure 3). The equipoise between the 226 
two groups persisted after adjusting for medications at discharge.  227 
When the analysis was stratified by BITA vs SITA grafting, the presence of BITA vs. SITA 228 
grafting did not significantly influence the comparison between off-pump and on-surgery for 229 
all outcomes of interest (Table 4, Figure 4).  However, when compared to on-pump, off-pump 230 
surgery was associated with a non-significant excess of cardiovascular deaths when SITA (off-231 
pump vs on-pump HR 2.0174; 95%CI 1.1-3.7) but not BITA grafts (off-pump vs on-pump 232 
HR1; 95%CI 0.45-2.3) were used (interaction P=0.21). Off-pump and on-pump surgery were 233 
comparable in terms of 10-year mortality and incidence of major adverse cardiac and 234 
cerebrovascular outcomes regardless the use of the RA (Supplementary Figure 2) or any 235 
multiple arterial grafting configuration (Supplementary Figure 3). 236 
A total of 159 participating surgeons were involved (Supplementary Figure 4). Ninety-eight 237 
surgeons performed on-pump only while off-pump was performed by 61 surgeons including 238 
21 surgeons who performed off-pump only. For 133 patients (59 off-pump, 74 on-pump), no 239 
information on participating surgeon was available and these were not included in this analysis. 240 
High off-pump volume surgeons were defined those performing over the 75th percentile. Based 241 
on the identified cut-off of least 10 off-pump procedures, 21 surgeons were classified as high 242 
volume off-pump performing 1075 procedures and the remaining 40 surgeons were classified 243 
as low-volume off-pump performing a total of 118 off-pump procedures. A total of 98 surgeons 244 
performed on-pump only. Patients characteristics, hospital outcomes stratified for off-pump vs. 245 
on-pump surgery and surgeon off-pump volume are summarized in Supplementary Table 4 246 
and 5. The use of BITA vs SITA graft (as treated) according to off-pump surgeon volume is 247 





perform BITA grafting. For low-volume off-pump surgeons, the use of off-pump technique did 249 
not influence the use of BITA or SITA grafting. Surgeons only performing on-pump surgery 250 
had the lowest rate of BITA grafting usage. 251 
10-year outcomes and adjusted treatment effect estimation on these outcomes stratified by 252 
surgeon off-pump volume are presented in Supplementary Table 7 and 8. When performed 253 
by low volume off-pump surgeons, off-pump surgery resulted in a significantly lower number 254 
of grafts and higher conversion rates while this trend was not observed when off-pump was 255 
performed by high volume off-pump surgeons.  When compared to on-pump surgery 256 
performed by “on-pump only” surgeons, off-pump surgery performed by low volume off-pump 257 
surgeons was associated with a significantly increased risk-adjusted incidence of 258 
cardiovascular death (HR 2.39; 95%CI 1.28-4.47; P=0.006) and increased risk of late stroke 259 
(HR 3.97; 95%CI 1.81-7.95; P<0.001) at 10 years. No difference in long term outcomes were 260 
demonstrated for off-pump surgery performed by high volume off-pump surgeons and for on-261 
pump surgery performed by high and low volume off-pump surgeons. BITA vs SITA grafting 262 
was not an effect modifier in the comparison between off-pump vs. on-pump surgery. 263 
 264 





Discussion   266 
The main finding of the present post-hoc analysis of the ART was that at 10 years, off-pump 267 
and on-pump surgery were associated with comparable outcomes including all-cause mortality 268 
and the composite of death, MI, stroke and repeat revascularization.  When compared to on-269 
pump, off-pump surgery was associated some advantage in terms of hospital outcomes 270 
including a lower rate of transfusion and post-operative atrial fibrillation.  271 
The use of SITA or BITA grafts was not found to be a significant effect modifier in the 272 
comparison between off-pump vs. on-pump surgery. It has been suggested that off-pump 273 
surgery may increase the risk of SVG failure6 without affecting graft patency of arterial 274 
conduits including BITA grafts. However, other reports have shown that both arterial and vein 275 
grafts durability is not reduced when off-pump surgery is performed by experienced 276 
surgeons.12 Available randomized comparative studies on long-term survival after off-pump 277 
vs. on-pump surgery included mainly procedure with SITA grafting.2–4 Observational studies 278 
have suggested that off-pump surgery with multiple arterial grafts but not vein grafts provides 279 
long-term outcomes comparable with those observed on-pump surgery with multiple arterial 280 
grafts.7  281 
Our findings suggest that off-pump surgery can safely performed regardless the use of BITA 282 
or SITA grafts. As the choice to perform on-pump or off-pump was based on individual 283 
surgeon’s preference, the overall experience in off-pump surgery in the ART was likely to be 284 
adequate and this can explain the equipoise between the two techniques regardless the graft 285 
selection adopted.12 However, it must be noticed that although not statistically significant, off-286 
pump surgery was associated with a non-significant excess of cardiovascular deaths in patients 287 
who received SITA graft but not in those with BITA grafts and this observation requires further 288 





We further analyzed the effect of off-pump surgery according to individual surgeon off-pump 290 
volume. When compared to on-pump performed by on-pump only surgeons, off-pump surgery 291 
performed by low-volume off-pump surgeons was associated with a significantly lower 292 
number of grafts and significantly increased risk of on-pump conversion, cardiovascular death 293 
and late stroke at 10 years. On contrary, off-pump surgery performed by high off-pump volume 294 
surgeon was associated with comparable number of grafts and 10 years outcomes.  295 
Off-pump volume at individual surgeon or hospital level are intuitive measures of ‘‘expertise’’ 296 
and a proxy of enhanced safety and quality5 and studies suggesting an increased risk of late 297 
mortality after off-pump surgery have been criticized by those who believe that surgeon 298 
experience plays a major role in determining outcomes. In the ROOBY trial,2 53 participating 299 
surgeons enrolled an average of only 8 patients per year during the study period and had 300 
unacceptably high conversion rates to on-pump surgery (12%) and incomplete 301 
revascularization (18%). Moreover, in 60% of the cases, a resident was the primary surgeon. 302 
These aspects might have contributed to the higher mortality observed in the off-pump group.  303 
In the CORONARY trial3 where each procedure was performed by a surgeon who had 304 
expertise in the specific type of surgery (completion of>100 cases of the specific technique, 305 
off-pump or on-pump), the difference in terms of number of grafts (3.0 vs 3.2) and incidence 306 
of incomplete revascularization (11.8% vs 10.0%) were only marginal  and off-pump and on-307 
pump surgery showed similar 5-year outcomes, including mortality with both techniques. 308 
Similar results were observed in the German off pump CABG trial in elderly patients study,4 309 
where surgeons were established experts with an average of 514 OPCAB procedures (median, 310 
322) performed, and where no significant differences between OPCAB and on-pump outcomes 311 
were found.   312 
A potential limitation of studies supporting the equipoise between the two techniques is the 313 
limited follow-up duration of 5 years and the ART trial, with 10-year follow-up, can provide 314 





pump surgery was performed at the individual surgeon’s discretion. Furthermore it is likely 316 
that the overall off-pump experience in the ART trial was adequate as witnessed by a similar 317 
number of grafts in the off-pump and on-pump groups, the very low off-pump to on-pump 318 
conversion rate and the equipoise between the two groups at 10 years. This hypothesis is 319 
supported by other reports from high off-pump volume centers.13   320 
Of note, the number of grafts performed with off-pump surgery and the incidence of conversion 321 
from off-pump to on-pump surgery in the ART trial was lower than those reported in other 322 
series.2 Finally, we also found that off-pump surgery was also associated with a non-significant 323 
reduction of myocardial enzymes and a lower rate of peri-operative MI as defined by the study 324 
protocol. It is well recognized that off-pump surgery is associated with a lower release of 325 
myocardial enzymes,14 but the clinical relevance of this observation remains unclear 326 
(Supplementary Table 8) also in view of comparable long-term outcomes between the two 327 
techniques. Moreover, the definition of perioperative MI after myocardial revascularization 328 
remains controversial.15  329 
 330 
Limitations 331 
The main limitation of the present study is its observational nature. The propensity technique 332 
can adjust only for measurable and included variables, and we cannot exclude a selection bias 333 
based on a nonmeasurable “eye-balling,” including the quality of the targets. We had no 334 
information on specific surgeon off-pump expertise, and we used the total number of off-pump 335 
procedures performed in the ART as a surrogate of off-pump expertise. We had no information 336 
on reasons for preferring off-pump over on-pump and vice versa across surgeon subgroups. 337 
The number of off-pump surgeries performed by low off-pump volume surgeons was relatively 338 
small thus increasing the risk of type I error. Therefore, subgroup analysis based on surgeon 339 





It should also be  noted by today’s standards that the ART population might be considered a  341 
relatively low risk subset of CABG patients (although the only formal exclusion criteria were 342 
evolving myocardial infarction,  redo surgery or the need for a single graft). It is possible that 343 
a difference between the two techniques could exist in patients at higher surgical risk.  344 
In conclusion, we found that when performed by experienced surgeons, off-pump was as safe 345 
and effective as on-pump surgery at long term follow-up regardless the use of BITA vs. SITA 346 
grafts. In the current era, an increasing number of patients with a high-risk profile are being 347 
referred for surgical revascularization, and off-pump surgery represents an attractive strategy 348 
to potentially reduce operative morbidity. However, the unique technical challenges of off-349 
pump surgery may lead to poorer outcomes during each surgeon’s ‘‘learning curve’’ and this 350 
further emphasizes the need for recognition of off-pump surgery as a subspecialty with a 351 
formally structured training program.16  352 










Central Message: 355 
In the Arterial Revascularization Trial, off-pump surgery long term outcomes were 356 
comparable to those of on-pump; this was not influenced by the use of single vs. bilateral 357 
internal thoracic artery. 358 
 359 
Perspective Statement: 360 
Off-pump surgery in experienced hands can achieve long term outcomes comparable to those 361 
observed after on-pump surgery and therefore off-pump should be considered a valid 362 
alternative to on-pump to reduce surgical morbidity following coronary bypass surgery. The 363 
choice of bilateral vs. single internal thoracic artery grafts should not influence the decision 364 
to adopt the off-pump technique. 365 
 366 
Abbreviated legend for Central Picture: 367 
Cumulative outcome incidence in the matched sample in the off-pump vs on-pump groups. 368 
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Figure Legend 421 
Figure 1. Mirrored histogram showing propensity score distribution in the off-pump vs on-422 
pump groups before (white) and after (blue and red respectively) matching.  423 
 424 
Figure 2. Cumulative incidence of all-cause death (left) and the composite of all-cause death, 425 
myocardial infarction (MI), stroke and revascularization (right) in the matched sample in the 426 
off-pump vs on-pump groups.   427 
  428 
Figure 3. Cumulative incidence of cardiovascular (CV) death, myocardial infarction (MI), 429 
stroke and revascularization in the matched sample in the off-pump vs on-pump groups. 430 
 431 
Figure 4. Cumulative incidence of all-cause death (left) and the composite of all-cause death, 432 
myocardial infarction (MI), stroke and revascularization (right) in the matched sample in the 433 
off-pump vs on-pump groups stratified for the use of single vs bilateral internal thoracic 434 
artery (SITA vs. BITA) grafts.  435 
















n  1078 1078   
Age year, mean (sd)  63.83 (8.88) 63.97 (8.74) 0.71 0.02 
Female n(%) 144 (13.4) 139 (12.9) 0.79 0.01 
Ethnicity n(%)    0.08 0.09 
     Caucasian  1001 (92.9) 1023 (94.9)   
     East Asian 1 ( 0.1) 4 ( 0.4)   
     South Asian   63 ( 5.8) 41 ( 3.8)   
     Afro-Carribean   0 ( 0.0) 2 ( 0.2)   
     African  0 ( 0.0) 4 ( 0.4)   
     Other  13 ( 1.2) 4 ( 0.4)   
Body Mass Index, mean (sd)  28.22 (4.18) 28.33 (3.91) 0.51 0.02 
Serum Creatinine mmol/l, mean 
(sd)  
99.07 (20.02) 97.86 (21.93) 0.18 0.05 
Unstable Angina n(%) 83 ( 7.7) 71 ( 6.6) 0.35 0.04 
Treated Hypertension n(%)  813 (75.4) 824 (76.4) 0.61 0.02 
Treated Hyperlipaemia n(%)  1012 (93.9) 1019 (94.5) 0.58 0.03 
Diabetes n(%)    0.59 0.04 
     No  850 (78.8) 847 (78.6)   
     Insulin Dependent  51 ( 4.7) 61 ( 5.7)   
     Non-Insulin Depended   177 (16.4) 170 (15.8)   
Smoking n(%)    0.31 0.05 
     Current smoker 157 (14.6) 136 (12.6)   
     Ex-smoker 585 (54.3) 642 (59.6)   
     Never 336 (31.2) 300 (27.8)   
COPD n(%) 28 ( 2.6) 30 ( 2.8) 0.89 0.01 
Asthma n(%) 53 ( 4.9) 53 ( 4.9) 1 <0.001 
Extracardiac arteriopathy n(%) 72 ( 6.7) 68 ( 6.3) 0.79 0.01 
Stroke n(%) 29 ( 2.7) 23 ( 2.1) 0.48 0.03 
Myocardial infarction n(%) 435 (40.4) 450 (41.7) 0.54 0.02 
PCI n(%) 182 (16.9) 190 (17.6) 0.69 0.02 
History of AF  n(%) 15 ( 1.4) 15 ( 1.4) 1  <0.001 
LVEF n(%)    0.30 0.03 
   ≥50%(good)  842 (78.1) 811 (75.2)   
   31-49% (moderate)  205 (19.0) 253 (23.5)   
   ≤30% (poor)  31 ( 2.9) 14 ( 1.3)   
APLT within 3 days n(%) 156 (14.5) 166 (15.4) 0.58 0.02 
RCA disease n(%) 695 (64.5) 703 (65.2) 0.75 0.02 
Mean vessel quality (1 good, 2 
moderate, 3 poor) mean (sd)  
1.73 (0.59) 1.69 (0.54) 0.11 0.07 
Endarterectomy n(%) 12 ( 1.1) 14 ( 1.3) 0.84 0.02 
  BITA n(%) 497 (46.1) 483 (44.8) 0.57 0.03 
  Radial artery usage n(%) 224 (20.8) 223 (20.7) 1 0.002 
 Saphenous vein graft n(%) 804 (74.6) 815 (75.6) 0.61 0.02 
COPD: chronic obstructive pulmonary disease; PCI: percutaneous coronary intervention; AF: atrial fibrillation; 443 
LEFT: left ventricular ejection fraction, APLT: antiplatelet therapy; RCA: right coronary artery; BITA: bilateral 444 











 1078 1078  
n grafts 3.21 (0.89) 3.10 (0.79) 0.88 
Conversion  27 ( 2.5)   
Red Blood Cell transfusion  n(%) 107 (10.1) 138 (13.2) 0.04 
Re-exploration  n(%) 32 ( 3.0) 41 ( 3.8) 0.34 
Need for IABP n(%) 50 ( 4.6) 42 ( 3.9) 0.45 
Renal Replacement Therapy n(%) 61 ( 5.7) 58 ( 5.4) 0.85 
Acute Kidney Injury n(%) 179 (17.4) 174 (17.1) 0.90 
Creatinine peak at 48 hours mmol/l, mean (sd)  111 (44) 107 (61) 0.18 
CK-MB at 24 hours, U/Lmean (sd) 36(194) 78(122) 0.06 
Troponin at 24 hours U/L mean (sd)  6.5 (24) 7.5 (61) 0.85 
Sternal Wound Complication n(%) 30 ( 2.8) 45 ( 4.2) 0.10 
Death n(%) 9 ( 0.8) 12 ( 1.1) 0.66 
Myocardial Infarction n(%) 10 ( 0.9) 28 ( 2.6) 0.01 
Stroke n(%) 14 ( 1.3) 15 ( 1.4) 1 
Repeat Revascularization n(%) 7 ( 0.6) 6 ( 0.6) 1 
Postoperative atrial fibrillation n(%) 247 (22.9) 295 (27.4) 0.02 
IABP: intra-aortic balloon pump 447 
 448 















N 1078 1078 HR [95%] P-value HR [95%] P-value 
All-cause death n(%) 232 (21.5) 215 (19.9) 1.1[0.84-1.4] 0.54 1.25[0.98.1.6] 0.07 
Cardiovascular death n(%) 90 ( 8.3) 70 ( 6.5) 0.97[0.57-1.6] 0.91 1.07[0.61-1.8] 0.82 
MI n(%) 49 ( 4.5) 64 ( 5.9) 0.78[0.53-1.2] 0.21 0.79[0.51-1.2] 0.28 
Stroke n(%) 50 ( 4.6) 47 ( 4.4) 1.2[0.45-1.5] 0.52 0.95[0.47-1.9] 0.88 
Revascularization n(%) 114 (10.6) 111 (10.3) 0.75[0.47-1.2] 0.21 0.70[0.44-1.1] 0.10 
Death/MI/stroke/revascularization n(%) 353 (32.7) 356 (33.0) 0.92[0.72-1.2] 0.47 0.95[0.75-1.2] 0.66 





Table  4. 10-year outcomes in the off-pump and on-pump group in the matched sample stratified for single vs bilateral internal thoracic artery  
 (SITA vs. BITA) grafts with treatment effect and interaction term analysis for outcomes of interest.  




















n  581 595  497 483   
All-cause death n(%) 136 (23.4) 125 (21.0) 1.2[0.84-1.8] 96 (19.3) 90 (18.6) 1.1[0.74-1.7] 0.68 
Cardiovascular death n(%) 54 ( 9.3) 39 ( 6.6) 2[1.1-3.7] 36 ( 7.2) 31 ( 6.4) 1[0.45-2.3] 0.21 
MI n(%) 28 ( 4.8) 32 ( 5.4) 0.89[0.34-2.4] 21 ( 4.2) 32 ( 6.6) 0.77[0.34-1.8] 0.82 
Stroke n(%) 34 ( 5.9) 29 ( 4.9) 1.1[0.46-2.4] 16 ( 3.2) 18 ( 3.7) 0.78[0.29-2.1] 0.68 
Revascularization n(%) 66 (11.4) 54 ( 9.1) 1.1[0.68-1.9] 48 ( 9.7) 57 (11.8) 0.75[0.41-1.4] 0.27 
Death/MI/stroke/revascularization n(%) 204 (35.1) 199 (33.4) 1[0.72-1.5] 149 (30.0) 157 (32.5) 0.9[0.63-1.3] 0.41 
